5-Cloro-2-Mercapto Benzothiazole

The wet-blue preservation stage in tanneries demands a mid-term fungistatic window that conventional TCMTB or OIT blends fail to cover reliably under high-pH chrome tanning conditions. 5-Chloro-2-mercaptobenzothiazole (CMBT) is introduced as a low-leach, broad-spectrum isothiazolinone-free biocide that retains activity at chrome- tanning liquor pH 3.8–4.2 where benzisothiazolinones hydrolyze. Biocidal product authorization follows EU BPR (EU) No 528/2012 for product-type 9 (leather preservation) and US EPA FIFRA 40 CFR 152 registration with tolerance exemption under 40 CFR 180.920 when used on hide/skin materials entering food-contact leather streams. ZDHC MRSL v3.1 conformity requires absence of free chlorophenol impurities at detection limits below 5 mg/kg. Application rate in the wet-blue drum operates at 0.08–0.15% calculated on wet-blue shaved weight, delivered as a 30% active aqueous dispersion stabilized with ethoxylated castor oil to prevent flocculation at chrome carryover. Float ratio is held at 1:1 with recirculated brine at 32–35°C; the drum runs for 45 minutes in loading phase and 30 minutes in exhaust phase, achieving >92% exhaustion via Cr(III) oligomer bridging confirmed by HPLC monitoring of drum filtrate. Subsequent fatliquoring and retanning chemistries show no antagonism with sulfited fish oils or melamine resin syntans. Finished leather compliance targets OEKO-TEX® STANDARD 100 Appendix 4 limits for benzothiazole residues and ISO 17234-1:2022 determination of banned azo colorants after re-cleaving. Terminal outputs are split suede for automotive seat covers, full-grain aniline upholstery, and children’s footwear where dimethyl fumarate limits are strictly enforced per EU 1907/2006 entry 61.

CMBT functions as a selective collector for tarnished galena and secondary copper sulfides in alkaline flotation pulps where conventional xanthate/xanthogen formate regimens lose selectivity against pyrite slimes. The mercaptobenzothiazole head groups chelate Pb²⁺ and Cu⁺ surface sites through S,N-hetero-ring coordination, while the 5-chloro substituent withdraws electron density from the ring, lowering pKa of the thiol to ~6.8 and enabling sustained collector activity at pH 8.5–10.2 without excessive froth mineralization. Regulatory adherence includes REACH (EC) No 1907/2006 registration for mining intermediates and local discharge consent under EU Water Framework Directive 2000/60/EC at pulp effluent selenium and zinc thresholds typically ≤0.03 mg/L. Dosage in a primary rougher bank ranges 25–80 g/t of mill feed, adjusted by the ratio of acid-soluble copper to total head grade determined by XRF every 2 hours. Conditioning is conducted at 60–65% solids density, pH 9.2–9.8 raised with lime, with a 3-minute collector conditioning slot followed by MIBC frother dosed at 15–25 g/t in a Denver D12 lab cell scaled to 10 m³ Outotec TankCell circuits. Air flow velocity is capped at 0.8–1.2 cm/s to avoid entrainment of gangue clays, and wash water is applied to froth crowder launders at 0.3 m³/h per metre of lip. Concentrate grades reach 24–28% Cu and 55–62% Pb after two stages of cleaning, with pyrite rejection indices exceeding 4.2 as measured by Hallimond tube microflotation benchmarks. Terminal products are copper cathode precursor concentrates sold to flash smelters and lead sulfate cake processed into automotive batteries.

Processing Safety in High-Speed Curing of NR/BR Tire Innerliners

High-temperature curing of bromobutyl-based innerliner compounds co-vulcanized with an NR/BR carcass skim demands a delayed-action sulfur crosslinking system that suppresses scorch before the bladder insertion window but does not retard cure rate at 160–180°C in a curing press. 5-Chloro-2-mercaptobenzothiazole is incorporated not as a primary accelerator but as a vulcanization activator-modulator that shifts the bound accelerator balance toward monosulfidic crosslinks when dosed alongside sulfenamide primaries. Compliance for this use covers FDA 21 CFR § 177.2600 for repeat-use rubber articles contacting dry and aqueous food (innerliner indirect food contact via migration), EU Regulation 10/2011 Annex II specific migration limits for 2-mercaptobenzothiazole analogues at ≤0.5 mg/kg food simulant, and the tire industry’s raw-material PAH limit of ≤1 mg/kg for the sum of 8 EU priority PAHs per ZEK 01.4-08. Recommended loading ranges 0.3–1.0 phr on a base NR/BR 70/30 blend, compensated with a reduction of secondary accelerator (DPG or TBBS) by 15–25% to maintain equivalent torque plateau. Mixing is performed in a 1.6-liter tangential internal mixer at fill factor 0.72, rotor speed 50 rpm, and dump temperature 130–135°C after a two-minute silica-silane coupling step. Sulfur is added on an open two-roll mill at 50°C nip gap 0.8 mm. Rheometer cure curves following ASTM D5289-21 at 170°C, 0.5° arc show t_s2 shift from 1.5 min to 2.3 min versus MBT-based control, while t₉₀ lengthens by only 10–15 seconds, translating to no productivity loss in segmented mold press cycles. Post-cure physicals by ISO 37:2023 Type 2 dumbbells indicate tensile strength retention above 93% relative to MBT, tear strength ( ISO 34-1:2022 Method B) within 48–52 kN/m, and dynamic crack growth resistance ( ASTM D813) improved by 30% after 50 kc due to reduced polysulfidic crosslink fraction. The innerliner compound is calendered to 0.8 mm gauge and laminated onto bromobutyl ply in a quadruplex extrusion head, forming a continuous air barrier that withstands 14-day oxygen permeability testing under ASTM D3985 at 60°C.

A formulation study across three accelerator variations is summarized below.

How Does 5-Chloro-2-Mercaptobenzothiazole Shift the Cure Profile of EPDM Profiles?

Continuous vulcanization of EPDM building profiles through a microwave-hot air tunnel at line speeds exceeding 35 m/min imposes extreme scorch safety requirements while the extrudate passes through the UHF magnetron zone at 2.45 GHz. In this production setup, the classic sulfur-donor system based on MBT or ZMBT frequently causes surface bloom within 48 hours post-extrusion due to low solubility of zinc mercaptide reaction by-products in the fully saturated ethylene-propylene backbone. Substitution with CMBT at equimolar thiol equivalent loading alters the blooming threshold because the 5-chloro substitution decreases molecular symmetry and increases the amorphous-phase solubility of the residual mercaptobenzothiazole species by roughly 35% compared to unsubstituted MBT, confirmed by ISO 1431-1:2023 static migration test on glass plates after 14-day humidity aging at 50°C/95% RH. Regulatory framework applicable to door gaskets and window seals invokes EN 681-1:2002 material requirements for elastomeric seals in building applications, the RAL-GZ 716 quality mark for PVCu systems, and restriction on 2-mercaptobenzothiazole class substances under Water Regulations Advisory Scheme (WRAS) BS 6920 if intended for potable water contact seals — at CMBT dosage below 0.8 phr, migration into 1 L of chlorine-free water extraction at 23°C for 72 h falls below 0.1 µg/L detection limit. The accelerator package relies on a combination of 0.5–1.2 phr CMBT with 0.2–0.4 phr tetramethylthiuram disulfide (TMTD) and 0.1–0.2 phr dipentamethylenethiuram tetrasulfide (DPTT) to achieve a hybrid crosslink network that retains compression set values under 25% after 24 h at 70°C per ISO 815-1:2022. The rubber stock is fed through a 12D cold-feed pin-barrel extruder with temperature profile 55/60/65°C (zone1/zone2/head), then passed under 2 × 10 kW magnetrons and into a 22 m hot-air circulating tunnel at 220°C air temperature. Residence time totals 3.2 minutes. Product acceptance testing includes surface gloss match ( 6 GU at 60° per ISO 2813) and no exudation under 24 h UV-A fluorescence inspection. End products are EPDM foamed and dense profiles for low-energy passive house fenestration, sunroof weatherstrip carriers, and HVAC damper seals meeting UL 94 HB flame category.

Copper removal rate suppression in acidic cupric chloride etching for fine-line PCB traces grows critical when the lateral etch factor exceeds 3.0 and the resist undercut reaches 15–25 µm on 35 µm copper foil. CMBT forms a chemisorbed monolayer on copper(l) surfaces even at concentrations below 20 mg/L in the spray etchant bath, with the 5-chloro substituent enhancing nitrogen-to‑copper coordinate bond strength by increasing π-acceptor character of the thiazole ring, corroborated by potentiodynamic polarization sweeps showing corrosion current density drop from 0.52 mA/cm² to 0.09 mA/cm² per ASTM G59-24 in 2.0 M HCl + 1.5 M CuCl₂ at 48°C. Environmental compliance demands IEC 62321:2013 RoHS testing for chlorine-free solderable surfaces and IPC-6012E Class 3 acceptance criteria for immersion silver finish thickness. Operational addition is made continuously from a 2 wt% stock solution in ethylene glycol monobutyl ether, metered into the sump to maintain 10–30 mg/L CMBT refractive index signal correlated to the etchant-specific gravity of 1.28–1.32 g/cm³ at 48–52°C. Spray nozzle pressure stabilizes between 1.4–1.8 bar with reciprocating oscillation at 0.5 Hz and breakpoint extraction adjusted to an oxidation-reduction potential range of 520–560 mV (Ag/AgCl). Bath life extension is measured by cupric chloride etchant regeneration cycles; CMBT-treated baths sustain 42 cycles before requiring dump versus 28 cycles for benzotriazole-protected baths under equal drag-out loss. Copper grain boundary attack is visualized via cross-sectional SEM, where line width loss at the copper-substrate interface is held within ±5 µm of the drawn feature. Finished boards enter electroless nickel immersion gold (ENIG) deposition, forming automotive engine control units and 5G millimeter-wave antenna substrates where circuit line/space targets reach 50/50 µm.

When Building-Block Reactivity Governs Benzothiazole Drug API Purity

The synthesis of 2-heteroatom-substituted benzothiazole pharmacophores — particularly antimycobacterial and cathepsin-B inhibitory chemotypes — utilizes CMBT as a bifunctional scaffold that undergoes tandem S-alkylation followed by amino-substitution at the 2-position under anhydrous polar aprotic conditions. Purity constraints demand ≥99.5% area by HPLC ( Ph. Eur. 2.2.29) with residual dichloromethane and DMF purge below 50 ppm as per ICH Q3C(R8) guidelines. The API intermediates manufacturing process must comply with ICH Q7 Good Manufacturing Practice for active pharmaceutical ingredients and REACH Annex XVII restrictions on N,N-dimethylformamide if used at tonne-scale in the EU. In a validated route, CMBT at 1.0 eq is suspended in tetrahydrofuran dried over 3 Å molecular sieves, potassium carbonate 1.5 eq is added, and the resulting thiolate is alkylated with 1.05 eq of 2-bromo-N-(4-fluorophenyl)acetamide at 0–5°C over 2 hours under nitrogen flow. The product S-alkylate is filtered through celite pad and precipitated in 10 vol of n-heptane at −10°C, yielding a free-flowing off-white powder with melting point 138–140°C (DSC at 10 K/min per ASTM E794-24). Further elaboration via Buchwald–Hartwig amination installs a morpholine moiety; CMBT’s chlorine substituent’s leaving-group aptitude avoids competitive hydrolysis that plagues unsubstituted MBT analogues during this step, thus improving coupled yield by 18–22% as evaluated in 6 parallel DoE runs. The final API precursor is recrystallized from isopropanol/water (70:30) to a polymorph consistently matching Form I by XRPD, which displays improved dissolution relative to the thermodynamically stable Form II. Production equipment consists of glass-lined reactors with jacket temperature control ±1°C, bottom flush valves to eliminate dead legs, and in-line PAT using ReactIR that monitors the disappearance of the 2550 cm⁻¹ thiol S–H stretching band. Pharmacopoeial compliance of the finished drug substance is supported by ICH Q6A decisions on impurity identification: any CMBT-derived genotoxic impurity is controlled below the threshold of toxicological concern at 1.5 µg/day per ICH M7(R2) when administered in a chronic therapeutic indication. Output APIs are tableted into immediate-release oral dosage forms for approval under EMA EMEA/H/C/005904 or similar ANDA frameworks.